December 3, 2009 – (Carlsbad, CA) Etaluma, Inc. will be represented (Booth 522) at the upcoming 49th American Society for Cell Biology (ASCB) Annual Meeting in San Diego, CA. The exhibits will be open December 6-9, 2009. Etaluma has been developing the LumaScope: its dramatically simplified personal inverted fluorescence microscope to be launched early 2010. A pilot model of the LumaScope will be available for demonstration at Etaluma’s booth (Booth 522.) Further information about possible applications, anticipated features, and anticipated options will be available at the booth. Etaluma is particularly interested in encouraging the open-source development of applications for the use of LumaScopes.
Etaluma also recently signed an agreement with Amgen, Inc. to acquire Amgen’s patent application and know-how relating to their internally developed “Flash” line of fluorescence and bioluminescence drug screening systems. Etaluma will now be able to make the FlashFluor cell-based screening platform available for sale to commercial and academic markets. FlashFluor is designed to provide rapidly interleaved fluorescence and luminescence reads for multiplexed screening and assays. For example, this allows it to perform calcium flux measurements while also measuring luciferase reporter readouts. Another application is to collect data on ion channel activity via membrane depolarization by measuring fluorescence while also collecting data on calcium flux by measuring aequorin bioluminescence. More information about the FlashFluor system will be available at Etaluma’s booth (Booth 522.)